The European Medicines Agency are preparing to present the results of their investigation into possible links between the Johnson & Johnson coronavirus vaccine and rare blood clotting cases later today.
Last week, Johnson & Johnson suspended its vaccine rollout in the EU after the US Food and Drug Administration recommended officials pause its use while the rare food clot cases are examined. Six cases of the rare clotting disorder were identified in the US, out of nearly 7 million people who were given the single-dose jab in the country.
Meanwhile, the US state department is to issue advice to Americans to avoid 80 per cent of countries worldwide, as the pandemic continued to “pose unprecedented risks to travellers”.
In a note to the media about its updated travel guidance, the department said this will bring it more in line with travel advisories from the Centres for Disease Control and Prevention (CDC) and “does not imply a reassessment of the current health situation in a given country”.